Page 6 - India News

Adani Group to invest Rs 1.3 trn in FY25; raise up to $3 bn in equity

Bulk of the investments will be in the airport and green energy businesses, says senior executive

Downtrend on charts for Nifty FMCG, Nifty Pharma: Check key levels

The Nifty FMCG Index reveals a near-term downtrend on charts, with a support level expected around 53,725

Nijjar amid extremism concerns

Chandra Arya, MP for Nepean, voiced discontent with his own government's stance. He referenced a Globe and Mail investigation revealing Canadian authorities' concerns about Nijjar's ties to extremism

Canadian MP slams parliament's tribute to Nijjar amid extremism concerns

Chandra Arya, MP for Nepean, voiced discontent with his own government's stance. He referenced a Globe and Mail investigation revealing Canadian authorities' concerns about Nijjar's ties to extremism

Private banks gain up to 4%; Axis, ICICI hit new highs; HDFC nears summit

At 02:04 pm; Nifty Private Bank index was up 1.7 per cent, as compared to 0.65 per cent rise in the Nifty 50 and 0.20 per cent gain in Nifty PSU Bank index.

Private banks gain up to 4%; Axis, ICICI hit new highs; HDFC nears summit

At 02:04 pm; Nifty Private Bank index was up 1.7 per cent, as compared to 0.65 per cent rise in the Nifty 50 and 0.20 per cent gain in Nifty PSU Bank index.

Sensex hits 78K: 3 reasons that led to 600-pts rally on BSE benchmark

The NSE Nifty crossed the 23,700 level for the first-time ever; while the Nifty Bank index zoomed past 52,700 levels.

JP Morgan India bond index inclusion impact: Weight cut likely for 3 EMs

To accommodate India's 10 per cent weight in the GBI EM index, HSBC said in a recent note, a reweighting will occur for other EM peers in the index, which will see a reduction in their weights.

Caste and billionaires: What data shows about the country's elite club

World Inequality Lab numbers show the caste composition of India's richest

Retail inflation steadily easing, food prices still a concern: RBI bulletin

In India, high-frequency indicators suggest the real GDP growth in Q1 FY2024-25 is broadly maintaining the pace it achieved in the preceding quarter

cost of unacceptable risks: RBI governor

Business models designed for profitability could contain vulnerabilities that may not be apparent, says Shaktikanta Das

Delhi's 52.9 to Iran's 66°C: Heatwaves are breaking records globally

Growth is important, but not at cost of unacceptable risks: RBI governor

Financial watchdog imposes Rs 18.82 cr penalty on crypto exchange Binance

World's largest cryptocurrency exchange violated India's anti-money laundering regulations, says Financial Intelligence Unit

From Delhi's 52.9 to Iran's 66°C: Heatwaves are breaking records globally

In India, high-frequency indicators suggest the real GDP growth in Q1 FY2024-25 is broadly maintaining the pace it achieved in the preceding quarter

India set to register biggest jump in coal-fired power in a decade

The world's most populous nation expects to add 15.4 gigawatts in the year through March 2025, the most in nine years

China's jet fuel exports up 68.2% on year in May on rising travel demand

China's kerosene output rose 32.7 per cent year-on-year in January-April, the most recent data available

India vs Pakistan: Who has more nuclear bombs and what is China up to?

The nine nuclear-armed nations of the world, including the US, Russia, France, China, India and Pakistan, continued to modernise their nuclear arsenals in 2023, says a recent SIPRI report

U^S' Kansas sues Pfizer for hiding Covid vaccine risks, making false claims

The lawsuit filed by Kansas, a US state, alleged that Pfizer promoted its vaccine's safety while hiding evidence linking it to pregnancy complications, such as miscarriages, and heart inflammations

w'sho do Andhra Pradesh and Bihar deserve special economic packages?

UP, Chhattisgarh, Jharkhand, Odisha, Rajasthan and hilly states including northeastern region also suit some of those criteria

US' Kansas sues Pfizer for hiding Covid vaccine risks, making false claims

The lawsuit filed by Kansas, a US state, alleged that Pfizer promoted its vaccine's safety while hiding evidence linking it to pregnancy complications, such as miscarriages, and heart inflammations